HealthEquity Additional Paid-in Capital 2014-2026 | HQY
HealthEquity additional paid-in capital from 2014 to 2026. Additional paid-in capital can be defined as the excess over par value paid for common securities.
- HealthEquity additional paid-in capital for the quarter ending April 30, 2026 was $1.902B, a 0.18% decline year-over-year.
- HealthEquity additional paid-in capital for 2026 was $1.917B, a 0.6% increase from 2025.
- HealthEquity additional paid-in capital for 2025 was $1.906B, a 4.17% increase from 2024.
- HealthEquity additional paid-in capital for 2024 was $1.829B, a 4.79% increase from 2023.
|
HealthEquity Annual Additional Paid-in Capital (Millions of US $) |
|
|---|---|
| 2026 | $1,917 |
| 2025 | $1,906 |
| 2024 | $1,829 |
| 2023 | $1,746 |
| 2022 | $1,677 |
| 2021 | $1,158 |
| 2020 | $819 |
| 2019 | $305 |
| 2018 | $261 |
| 2017 | $232 |
| 2016 | $200 |
| 2015 | $157 |
| 2014 | |
| 2013 | |
|
HealthEquity Quarterly Additional Paid-in Capital (Millions of US $) |
|
|---|---|
| 2026-04-30 | $1,902 |
| 2026-01-31 | $1,917 |
| 2025-10-31 | $1,917 |
| 2025-07-31 | $1,919 |
| 2025-04-30 | $1,905 |
| 2025-01-31 | $1,906 |
| 2024-10-31 | $1,893 |
| 2024-07-31 | $1,887 |
| 2024-04-30 | $1,863 |
| 2024-01-31 | $1,829 |
| 2023-10-31 | $1,809 |
| 2023-07-31 | $1,785 |
| 2023-04-30 | $1,765 |
| 2023-01-31 | $1,746 |
| 2022-10-31 | $1,733 |
| 2022-07-31 | $1,713 |
| 2022-04-30 | $1,693 |
| 2022-01-31 | $1,677 |
| 2021-10-31 | $1,663 |
| 2021-07-31 | $1,649 |
| 2021-04-30 | $1,631 |
| 2021-01-31 | $1,158 |
| 2020-10-31 | $1,140 |
| 2020-07-31 | $1,127 |
| 2020-04-30 | $827 |
| 2020-01-31 | $819 |
| 2019-10-31 | $806 |
| 2019-07-31 | $784 |
| 2019-04-30 | $316 |
| 2019-01-31 | $305 |
| 2018-10-31 | $298 |
| 2018-07-31 | $290 |
| 2018-04-30 | $276 |
| 2018-01-31 | $261 |
| 2017-10-31 | $255 |
| 2017-07-31 | $247 |
| 2017-04-30 | $239 |
| 2017-01-31 | $232 |
| 2016-10-31 | $227 |
| 2016-07-31 | $220 |
| 2016-04-30 | $211 |
| 2016-01-31 | $200 |
| 2015-10-31 | $198 |
| 2015-07-31 | $195 |
| 2015-04-30 | $163 |
| 2015-01-31 | $157 |
| 2014-10-31 | $155 |
| 2014-07-31 | $20 |
| 2014-04-30 | $0 |
| 2014-01-31 | |
| 2013-10-31 | $0 |
| 2013-07-31 | $0 |
| 2013-01-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $6.586B | $1.313B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |